Target intelligence / Profile preview

Mitochondrion (tumor cell)

Molecular classification
Organelle, Intracellular organelle, Other
01

Overview

Mitochondria in tumor cells are double-membrane organelles crucial for energy production, metabolism, and regulation of cell death and survival pathways[1][2][3][4][5]. In cancer, mitochondrial networks display profound structural, functional, and dynamical alterations, including increased fission and fusion activity, changes in cristae organization, and close interactions with other organelles such as lipid droplets[1][2][5]. These features underpin metabolic reprogramming, support rapid proliferation, contribute to metastatic capacity, and often confer resistance to apoptosis and therapeutic interventions[1][2][5]. Mitochondria also participate in the generation of reactive oxygen species and bioenergetic adaptation under tumor microenvironment conditions such as hypoxia[2][3]. While the term "tumor cell mitochondria" is not a canonical name for a specific molecular target (such as a protein or receptor), mitochondria as a class of organelle represent a validated and increasingly investigated therapeutic vulnerability in cancer biology[1][5].

Other names
Tumor cell mitochondriaCancer cell mitochondriaMitochondria in cancer cells
02

Mechanism of action

Inhibition of mitochondrial fission (e.g., via Drp1 inhibition), Disruption of oxidative phosphorylation (OXPHOS), Induction of apoptosis through modulation of mitochondrial pathways

03

Biological functions

Energy productionMetabolismApoptosisCell proliferationCell deathSignal transductionRegulation of oxidative stress
04

Disease associations

CancerOther
05

Safety considerations

Mitochondria are essential for the viability of all cells; off-target effects may impair normal tissue functionRisk of toxicity due_to general suppression of cellular metabolismLimited selectivity for tumor vs. normal mitochondriaPotential for inducing excessive oxidative stress or compromising cardiac/skeletal muscle function
06

Interacting drugs

mDIVI1 (mitochondrial fission inhibitor)

1 more in the full profile.

07

Biomarkers

mtDNA content/heteroplasmyMitochondrial membrane potential (ΔΨm)Drp1 activityMitochondrial network structure (ultrastructural features)

Beyond the preview

Go deeper on Mitochondrion (tumor cell).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrion (tumor cell).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call